postpartum%20depression
POSTPARTUM DEPRESSION

Postpartum depression is the occurrence of a major depressive episode within 4 weeks following delivery or up to a year after childbirth.

It may peak at 2-4 weeks and 10-14 weeks after childbirth.

Symptoms are similar to that of major depression but with additional features distinctive of the postpartum period like feelings of being overwhelmed and inadequate as a parent.

Postpartum%20depression Patient Education

Patient Education

  • Counsel patient and her partner/family members regarding PPD, possible treatments and their risks and benefits, the risks and benefits of breastfeeding on or off medical therapy, the risks to the patient or the infant when discontinuing medication, and coping strategies, eg social support, giving time for self
  • Recommend adequate nutrition and sleep andregular exercise
    • Advise patient regarding balancing the benefits of breastfeeding with her need to sleep as the lack of sleep can worsen depressive symptoms
  • Relaxation techniques (eg yoga, tai chi, meditation, art therapy, etc) may help in managing anxiety and stress
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 5 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
5 days ago
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Jairia Dela Cruz, 18 hours ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.